# CytomX Therapeutics, Inc.: Form 8-K, filed Jul 3, 2023

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2023-07-03
- Accepted by EDGAR: Jun 30, 2023, 19:07 ET
- Period: 2023-06-29
- Accession: 0001193125-23-180722
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312523180722/d500160d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312523180722/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312523180722/d500160d8k.htm

Filed Jul 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-180722. Last ingested by Listed: Nov 5, 2026, 17:07 ET. No prices; not investment advice.